HomeRVPH • NASDAQ
add
Reviva Pharmaceuticals Holdings Inc
Previous close
$0.52
Day range
$0.53 - $0.58
Year range
$0.25 - $4.28
Market cap
65.03M USD
Avg Volume
6.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.03M | -52.38% |
Net income | -4.01M | 52.06% |
Net profit margin | — | — |
Earnings per share | -0.06 | 76.00% |
EBITDA | — | — |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.18M | 137.16% |
Total assets | 14.33M | 87.85% |
Total liabilities | 9.78M | -44.45% |
Total equity | 4.55M | — |
Shares outstanding | 115.06M | — |
Price to book | 10.45 | — |
Return on assets | -77.59% | — |
Return on capital | -479.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.01M | 52.06% |
Cash from operations | -5.59M | -31.78% |
Cash from investing | — | — |
Cash from financing | 8.41M | 132.16% |
Net change in cash | 2.82M | 555.23% |
Free cash flow | -4.17M | -192.05% |
About
Founded
2018
Headquarters
Website
Employees
14
